Latest United Kingdom Startup Funding Rounds
Startup funding in United Kingdom: recent rounds, the companies behind them and their participating investors.
- Rounds
- 652 All time
- Disclosed funding
- $38.4B 521 disclosed amounts
- Median round
- $7.7M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
NayaraCompany profile AI patient companions that support care journeys and keep clinical teams informed between appointments. AI patient companions that support care journeys and keep clinical teams informed between appointments. | Undisclosed | Pre-seed | Healthtech | United Kingdom | Investors | |
| H HaidoCompany profile An AI personal finance service founded by early Revolut employees Veronique Barbosa and Tom Reay. An AI personal finance service founded by early Revolut employees Veronique Barbosa and Tom Reay. | Undisclosed | Undisclosed | Fintech | United Kingdom | Investors | |
Potential SciencesCompany profile AI and quantum chemistry software that helps researchers calculate molecular properties for drug discovery. AI and quantum chemistry software that helps researchers calculate molecular properties for drug discovery. | Undisclosed | Seed | AI | United Kingdom | Investors | |
| F FluoRokCompany profile FluoRok develops manufacturing processes for fluorochemicals that bypass hazardous hydrogen fluoride. FluoRok develops manufacturing processes for fluorochemicals that bypass hazardous hydrogen fluoride. | $30M | Series A | Industrial tech | United Kingdom | Investors | |
MindMaxCompany profile MindMax develops conversational AI tutoring for people preparing for exams and learning new skills. MindMax develops conversational AI tutoring for people preparing for exams and learning new skills. | £2.5M | Undisclosed | Edtech | United Kingdom | Investors | |
| AT Alethio TherapeuticsCompany profile Oxford spin-out developing targeted medicines for myeloproliferative neoplasms, a group of blood cancers. Oxford spin-out developing targeted medicines for myeloproliferative neoplasms, a group of blood cancers. | $90M | Series A | Biotech | United Kingdom | Investors | |
| b bit.bioCompany profile Creates functional, human-relevant cells and models for research, drug discovery, and development Creates functional, human-relevant cells and models for research, drug discovery, and development | $25M | Series DSeries C+ | Biotech | United Kingdom | Investors | |
SupaCompany profile Supa acquires local property management firms and equips their teams with technology for maintenance, service charges and building compliance. Supa acquires local property management firms and equips their teams with technology for maintenance, service charges and building compliance. | £21M | Seed financing combining equity and debtSeed | Proptech | United Kingdom | Investors | |
Crediflow AICompany profile Crediflow AI automates document preparation, financial analysis and credit memos for commercial lenders. Crediflow AI automates document preparation, financial analysis and credit memos for commercial lenders. | £1.5M | Equity financingUndisclosed | Fintech | United Kingdom | Investors | |
| 1 1nhalerCompany profile 1nhaler develops a compact, single-dose dry powder inhaler made predominantly from cardboard. 1nhaler develops a compact, single-dose dry powder inhaler made predominantly from cardboard. | £2.2M | Follow-on fundingUndisclosed | Healthtech | United Kingdom | Investors |